ADAR1 Capital Management »

Insmed shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Insmed (INSM) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Insmed

Tip: Access up to 7 years of quarterly data

All positions including Insmed held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Insmed by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $265k 3.6k 73.00
2024-06-30 $26M 393k 67.00
2024-03-31 $46k 1.7k 27.13

More positions owned by ADAR1 Capital Management

Cytokinetics Com New (CYTK)
Protagonist Therapeutics (PTGX)
Bridgebio Pharma (BBIO)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Royalty Pharma Shs Class A (RPRX)
Keros Therapeutics (KROS)
Ascendis Pharma A/s Sponsored Adr (ASND)
Zura Bio Class A Ord Shs (ZURA)
Zai Lab Adr (ZLAB)
Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Aa Mission Acquisition Corp Ord Shs Cl A (AAM)
Mineralys Therapeutics (MLYS)
Syndax Pharmaceuticals (SNDX)

View all positions for ADAR1 Capital Management

Top funds holding Insmed

Vanguard Group
BlackRock
T. Rowe Price Associates
Darwin Global Management
FMR
Capital Research and Management Company - Division 3
State Street Corporation
Baker Bros. Advisors
Geode Capital Management
Jpmorgan Chase & Co
Rtw Investments
Artisan Partners Limited Partnership
Franklin Resources
Ameriprise Financial
Alliancebernstein

View all funds holding Insmed